A California woman filed a class action suit against 23andMe last week, days after the FDA released a scathing open letter criticizing the DNA-testing service for operating without approval.
Lisa Casey’s complaint, filed in a California court, is seeking at least $5 million in damages from 23andMe for allegedly making misleading claims about the tests’ ability to provide genetic information about conditions like breast cancer and diabetes, Gigaom reports. The complaint alleges the test results are “not supported by any scientific evidence.”
The damages sought includes a $99 refund for “tens or hundreds of thousands” of people who purchased the test.
The FDA requested the Google-backed firm stop marketing and selling its product last month unless it can provide evidence that the results are reliable.